Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of HSK31858 in Non-cystic Fibrosis Bronchiectasis
NCT07616375Phase 3Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 3 trial of HSK31858 in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Sep 2025; status: recruiting.
02
Drugs
HSK31858
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT07616375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616375.